Amgen s Amgen goes its own way

There are investments. For example, the establishment of a joint venture with Zhejiang Betta and the signing of a memorandum of understanding (MOU) with ShanghaiTech University to advance biopharmaceutical and translational research in China. As part of the agreement, Amgen plans to establish an Amgen China R&D Center on the campus of ShanghaiTech University.

Amgen was founded in 1980 by a group of scientists and venture capitalists. Dr. George B Rathmann, formerly of Abbott Laboratories, was one of the company's founders and served as its first chairman and year after the company began operations, with venture capitalists and two other major investment firms raising a total of $19 million in start-up capital. The company is located in Thousand Oaks, California, which is close to the University of California and the California Institute of Technology.

Since there has been no product on the market, the company has raised funds through public offerings in 1983, 1986 and 1987 to maintain the company's survival. Amgen Inc. is codenamed AMGN on the NASDAQ** market in the United States.

Abroad, especially the United States, its investment in biotechnology is second only to its investment in aerospace, and the annual profit of a medium-sized biopharmaceutical company in the United States is almost the sum of the annual profits of all biological enterprises in our country.

Biopharmaceuticals have tremendous potential for development, and the shifts in the 21st century are; the shift of the information industry to the biotechnology industry; Biopharmaceuticals are more profitable, for example, Amgen Biologics has reduced all input costs in less than half a year after it was launched, and the net profit has reached more than $1 billion in only 2 to 3 years.

I won't say much about the rest.

However, I believe that our country will gradually pay attention to it.

On March 29, 2004, Amgen announced that it would acquire an 80% stake in Tularik for $1.3 billion**. Dularic doesn't have a product on the market yet, but the South San Francisco-based company is known for developing drugs for esophageal cancer, inflammation, diabetes and obesity. Unlike ordinary drug developers, the new drugs developed by this company are using gene technology to achieve the best purpose, so the acquisition of this company is conducive to expanding the market and ability of Amgen to develop new drugs.

Under the terms of the agreement, Amgen will acquire Dularic for the equivalent of $25 per share, which is 47% more than the latter's price on the 26th. Dularic had an operating income of $30.7 million last year, with a loss of $100 million, equivalent to a loss of dollars per share; Amgen, on the other hand, had revenues of $100 million and profits of $100 million, equivalent to earnings per share dollars.

Suggestions and opinions, I hope that the company's management will be more humane and fair, and I hope that the company's rules and regulations will be more perfect.

Employees' opinions and suggestions on the company's management.

A ** shows the views and suggestions of Amgen employees on the company. 80% of Amgen's employees generally agree that Amgen's treatment (salary, bonuses), benefits (vacations, insurance, gym, nursery), environment and facilities are very good.

Although employees generally approve of benefits, 50% of them are seriously dissatisfied with career development, such as lack of promotion opportunities, unfair promotion, and opaque policies, as well as bureaucracy, management skills, lack of product lines, and declining product sales. As one employee said, "The treatment, vacations, insurance, etc., make Amgen different from other companies, but if we take these out, Amgen is no different from other companies, and we can only rely on profit to retain employees!" ”

Amgen has not yet arrived in Chinese mainland. There are only three points in the Asia-Pacific region: Hong Kong, India and Japan. Now North America is laying off workers.

Amgen is secretly negotiating an acquisition or sales partnership involving a domestic pharmaceutical up-and-com.

It is expected to introduce its key products in 2013.

Denosumab (denosumab) is used for postmenopausal women with osteoporosis at high risk of fractures, specifically those with a history of osteoporotic fractures, or multiple risk factors for fractures; or for patients who have failed or are intolerant of other available osteoporosis**; Denosumab can also be used to prevent bone 62-related events in 911 patients with tumors that have metastasized and damaged bone mass in 156. Digitally practiced ways.

Denosumab is an inhibitor used to prevent bone-related events in patients with tumors whose cancer has metastasized and damaged bone, and is available in Hong Kong Xinxite Pharmaceutical****.

Denosumab, which was used in the early days for osteoporosis, was later found to be able to treat giant cell tumors of bone. The growth of simulated osteoclasts, combined with surgery, has reduced the rate. It is currently available in Hong Kong and Taiwan.

Used for **156 bone macro, 666 cell tumors and 91162 bone metastases and multiple myeloma drugs, 120mg and one is **osteoporosis is 60mg are all Amgen in the United States, look at the beginning hahaha.

There are several versions, the price is not the same, and it is also listed in China, about 5300 licensed, 2600 in Taiwan, and more than 1000 in Turkey. The best cost performance is the original version, which is also the original research, not imitation.

5,298 yuan in China, about 2,000 in Turkey, and more than 3,000 in Taiwan, all of which are 15,666 factories, 6 911 and 62 Amgen companies in the United States, are all the same Domestic ones are not included in medical insurance.

Specifically**Each pharmacy has differences, you can compare them first, but Dehua's should be the cheapest.

According to the latest data collection, Amgen Biopharmaceutical's original drug specification is 60mg 1ml box, ** in US dollars, which is a huge expense! However, there is no approval for the marketing of denosumab in China, so more and more patients choose the original drug marketed in Turkey in the United States, with a specification of 125mg 1ml box, and the price is equivalent to about 3,000 yuan.

Amgen Biopharma (Shanghai) **** is a limited liability company (wholly owned by Taiwan, Hong Kong and Macao legal persons) registered in Shanghai on 2018-03-21, with its registered address at Room 307, 3rd Floor, Building 4, No. 222 Meiyo Road, China (Shanghai) Free ** Pilot Zone.

Amgen Biopharma (Shanghai)****'s unified social credit** registration number is 91310115MA1K41U531, and the enterprise is currently in operation.

The business scope of Amgen Biopharma (Shanghai) is: international, re-export, inter-enterprise and intra-regional, wholesale, commission, import and export and other supporting services of western medicine and traditional Chinese medicine, warehousing and distribution business in the region (except for dangerous goods), commercial simple processing in the region, consulting services, biotechnology (except human stem cells and Kevodane defect diagnosis and ** technology development, technical consulting, technical services, and technology transfer in the professional field of medical science and technology (except for human stem cell and gene diagnosis and development and application of advanced technology). [For projects subject to approval in accordance with the law, business activities can only be carried out after approval by relevant departments].

Within the scope of this province, the registered capital of the current enterprise belongs to the general.

Amgen Biopharma (Shanghai) has invested in 0 companies and has 4 branches.

Through corporate credit.

I checked, and it seems that Xinte does not sell Dinosuma.

This is a new drug from Amgen in the United States, and there is still a lot of controversy about its indications. There are currently 2 types of Denosumab on the market:

Prolia, suitable for postmenopausal women, injections every six months , this is not for you.

XGEVA, injected every 4 weeks; That's what you're going to buy. It is best to supplement with calcium and vitamin D during use. As far as I understand, Hong Kong Zhitai can be found.

Room 10B, 4/F, Tower A, Hung Hom Commercial Centre, 39 Ma Tau Wai Road, Kowloon, Hong Kong.

If you want a doctor in Hong Kong to prove it, some of them have pharmacists who can sell them

It is also possible to see a doctor and then prescribe medication, which is more secure.